Even if ACE inhibitors or AT1R blockers are well-established in the treatment of hypertension and other cardiovascular complications, their inhibition in patients with chronic comorbidities appears at the moment unjustified or at least questionable [152,177]. Here, AGTR1 is linked to Hypertension.